# Chuquiraga (Chuquiraga oppositifolia)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/chuquiraga-chuquiraga-oppositifolia
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Chuquiraga oppositifolia D. Don, Chuquiragua, Andean spiny herb, Asteraceae Andean shrub, páramo medicinal plant

## Overview

Chuquiraga oppositifolia contains sesquiterpene lactones, polyphenols, and flavonoids that scavenge [reactive oxygen species](/ingredients/condition/antioxidant) and modulate antioxidant enzyme activity, including superoxide dismutase and catalase, to attenuate oxidative stress and [inflammation](/ingredients/condition/inflammation). In vitro and rodent studies using closely related Chuquiraga species have demonstrated up to a 1.97-fold increase in reduced [glutathione](/ingredients/condition/detox) at 100 µg/mL and reductions in malondialdehyde to 0.29 times control values, though no human clinical trials have yet validated these findings.

## Health Benefits

- **Antioxidant Defense Enhancement**: Leaf extracts of Chuquiraga species elevate reduced [glutathione](/ingredients/condition/detox) (GSH) levels up to 1.97-fold and catalase activity up to 120.98% of control, strengthening cellular defenses against oxidative damage through upregulation of the endogenous antioxidant enzyme network.
- **Lipid Peroxidation Inhibition**: Bioactive sesquiterpene lactones and polyphenols protect erythrocyte membranes from oxidative assault, reducing malondialdehyde (MDA) to as low as 0.29 times control values in experimental models, indicative of significant inhibition of membrane lipid peroxidation.
- **[Anti-Inflammatory](/ingredients/condition/inflammation) Activity**: Methanol extracts of related Chuquiraga spinosa demonstrate anti-inflammatory effects correlated directly with polyphenolic content, with rodent chronic inflammation models showing paw swelling area (PSA) reductions up to 70.78% and plethysmometer index (PI) reductions up to 48.28% at 250–500 mg/kg doses.
- **[Free Radical Scaveng](/ingredients/condition/antioxidant)ing**: Chuquiraga leaf extracts exhibit potent scavenging of DPPH, superoxide anion (O₂⁻), and hydrogen peroxide (H₂O₂) radicals, with leaf fractions consistently outperforming flower fractions, attributed to higher concentrations of total phenols (up to 130.13 mg gallic acid equivalents/g dry extract).
- **Superoxide Dismutase Upregulation**: Animal model data from related Chuquiraga species indicate SOD activity increases to approximately 104.13% of control following extract administration, suggesting the plant supports [mitochondrial](/ingredients/condition/energy) and cytosolic antioxidant enzyme expression under conditions of oxidative challenge.
- **Peroxidase System Support**: Plasma membrane redox system (PMRS) peroxidase activity is elevated up to 1.20 times control values in experimental models, indicating the plant's phytochemicals may support cellular detoxification pathways beyond classical cytosolic antioxidant enzymes.
- **Traditional [Adaptogen](/ingredients/condition/stress)ic Use in High-Altitude Stress**: Indigenous Andean populations have used Chuquiraga species empirically to manage conditions associated with physical stress at high altitude, where oxidative burden and inflammation are physiologically elevated, though mechanistic human evidence for this application remains absent.

## Mechanism of Action

The primary mechanisms of Chuquiraga oppositifolia and closely related species center on polyphenol-mediated free radical neutralization and transcriptional upregulation of endogenous antioxidant defenses. Flavonoids such as quercetin derivatives donate hydrogen atoms to quench DPPH, superoxide, and hydrogen peroxide radicals directly, while also chelating transition metals that catalyze the Fenton reaction, thereby interrupting [lipid peroxidation](/ingredients/condition/antioxidant) chain reactions at the membrane level. Sesquiterpene lactones, characterized by an α,β-unsaturated carbonyl lactone moiety, are hypothesized to modulate NF-κB signaling by alkylating cysteine residues on IκB kinase, suppressing [pro-inflammatory cytokine](/ingredients/condition/inflammation) transcription in a manner consistent with other Asteraceae sesquiterpene lactones such as parthenolide. The combined polyphenolic and sesquiterpene content appears to induce compensatory upregulation of GSH synthesis, catalase, SOD, and PMRS peroxidase activity, suggesting activation of Nrf2/ARE pathway elements, though direct Nrf2 engagement has not yet been confirmed experimentally for this species.

## Clinical Summary

No human clinical trials have been conducted on Chuquiraga oppositifolia or any Chuquiraga species as of the available literature, making it impossible to draw clinical conclusions about efficacy, effective dose, or safety in human populations. The most relevant preclinical data come from rodent chronic inflammation models using Chuquiraga spinosa extracts at 250–500 mg/kg, demonstrating meaningful reductions in inflammatory biomarkers, but these dose levels do not correspond to established human equivalents and the studies lack peer-reviewed full-text validation in internationally indexed journals. In vitro studies provide biochemically plausible mechanistic support for [antioxidant](/ingredients/condition/antioxidant) and [anti-inflammatory](/ingredients/condition/inflammation) claims, showing consistent upregulation of GSH, SOD, catalase, and peroxidase alongside reduced MDA, but in vitro findings frequently overestimate in vivo activity due to bioavailability and metabolic transformation variables. Confidence in any clinical application remains very low; this ingredient should be regarded as a candidate for future investigation rather than an evidence-supported therapeutic agent.

## Nutritional Profile

Chuquiraga oppositifolia leaves contain a rich array of secondary metabolites with documented or inferred nutritional and bioactive significance. Total phenolic content in closely related Chuquiraga spinosa reaches 130.13 ± 1.02 mg gallic acid equivalents per gram of dry extract, while total flavonoids measure approximately 93.37 ± 1.72 mg quercetin equivalents per gram of dry extract, placing this genus among polyphenol-dense Andean botanicals. Phytochemical screening confirms the presence of sesquiterpene lactones, triterpenes, steroids, alkaloids, carotenoids, and vitamin C, though precise concentrations for C. oppositifolia specifically have not been independently quantified. Bioavailability of polyphenols from crude plant extracts is generally moderate and subject to intestinal [metabolism](/ingredients/condition/weight-management), [gut microbiome](/ingredients/condition/gut-health) transformation, and matrix effects that reduce systemic availability compared to isolated compounds; no specific bioavailability studies for this species exist.

## Dosage & Preparation

- **Traditional Infusion (Herbal Tea)**: Dried aerial parts steeped in boiling water for 10–15 minutes; typical Andean preparation uses approximately 5–10 g of dried plant material per 250 mL of water, consumed 1–3 times daily, consistent with regional Asteraceae decoction practices.
- **Crude Methanolic Extract (Research Grade)**: In vitro studies employed concentrations of 25–100 µg/mL; rodent studies used 250–500 mg/kg body weight as crude methanol extracts — no human equivalent dose has been established or validated.
- **Standardized Extract (Not Yet Commercially Available)**: No commercially standardized supplement form (e.g., capsule, tablet, tincture) with defined phytochemical content has been reported for C. oppositifolia specifically; related species remain similarly uncommercialised in mainstream supplement markets.
- **Standardization Benchmark (Hypothetical)**: Based on related species data, a meaningful extract might be standardized to total phenols ≥100 mg gallic acid equivalents/g dry extract and flavonoids ≥80 mg quercetin equivalents/g dry extract, mirroring assay conditions in C. spinosa research.
- **Timing Notes**: No human pharmacokinetic data exist to inform optimal dosing timing; traditional use suggests daily consumption with meals, consistent with general botanical [anti-inflammatory](/ingredients/condition/inflammation) practice.

## Safety & Drug Interactions

No formal safety studies, toxicology assessments, or documented adverse event profiles have been published for Chuquiraga oppositifolia in humans or in controlled animal toxicity trials, representing a significant gap in the evidence base. Traditional use among Andean indigenous populations over generations without widely reported adverse effects tentatively suggests low acute oral toxicity at typical infusion doses, but this ethnobotanical inference cannot substitute for rigorous toxicological evaluation. Sesquiterpene lactones as a compound class are known in other Asteraceae species (e.g., feverfew, arnica) to cause contact dermatitis in sensitive individuals and may trigger allergic reactions in persons with established Asteraceae/Compositae family hypersensitivity; this cross-reactivity risk should be considered for C. oppositifolia by analogy. No drug interaction data exist; however, given the plant's [antioxidant](/ingredients/condition/antioxidant) and potential [anti-inflammatory](/ingredients/condition/inflammation) mechanisms, theoretical caution is warranted in combination with anticoagulants, immunosuppressants, and non-steroidal anti-inflammatory drugs until interaction studies are performed. Use during pregnancy or lactation is not recommended due to complete absence of safety data in these populations.

## Scientific Research

The evidence base for Chuquiraga oppositifolia specifically is extremely limited, with no published human clinical trials identified as of current literature; available data derive almost exclusively from in vitro assays and rodent models conducted primarily on the closely related species Chuquiraga spinosa and Chuquiraga jussieui, whose phytochemical profiles are considered broadly analogous. Rodent studies using 250–500 mg/kg crude methanol extracts have reported statistically significant [anti-inflammatory](/ingredients/condition/inflammation) outcomes including PSA reductions up to 70.78% and PI reductions up to 48.28% in chronic inflammation models, though study methodology details such as randomization, blinding, and sample sizes are not fully reported in available summaries. In vitro [antioxidant](/ingredients/condition/antioxidant) assays confirm dose-dependent radical scavenging and erythrocyte membrane protection, with quantified enzyme activity data providing mechanistic plausibility, but these models do not translate directly to human pharmacokinetic or pharmacodynamic outcomes. Overall, the evidence level is preclinical and exploratory; the extrapolation of these findings to human supplementation requires rigorous clinical investigation that has not yet been undertaken.

## Historical & Cultural Context

Chuquiraga oppositifolia occupies a significant place in the ethnobotanical heritage of Andean indigenous communities in Ecuador, where it grows amid the austere grassland ecosystems of the páramo at elevations that challenge most other flowering plants. Known colloquially in Quechua-speaking communities as part of a broader class of medicinal highland shrubs, Chuquiraga species are traditionally sought for their perceived capacity to support resilience against cold, physical exertion, and [inflammatory](/ingredients/condition/inflammation) ailments common in high-altitude life. Preparation has historically involved infusions or decoctions of the aerial parts, with leaves regarded by practitioners as the most therapeutically potent portion, a view that aligns with modern phytochemical analyses showing higher bioactive concentrations in leaves than flowers. Despite this deep cultural roots, formal ethnobotanical documentation of C. oppositifolia's specific uses remains sparse compared to the more widely studied C. jussieui, which has attracted greater regional academic interest particularly in Ecuador.

## Synergistic Combinations

Chuquiraga oppositifolia's polyphenol and sesquiterpene lactone content may act synergistically with other Andean [antioxidant](/ingredients/condition/antioxidant) botanicals such as Maca (Lepidium meyenii) or Cat's Claw (Uncaria tomentosa), where complementary mechanisms — Nrf2 activation, NF-κB inhibition, and direct radical scavenging — could provide broader [anti-inflammatory](/ingredients/condition/inflammation) and antioxidant coverage than any single agent alone. The flavonoid fraction, particularly quercetin-type glycosides, is known to enhance the bioavailability and regeneration of vitamin C through redox cycling, suggesting that traditional preparations combining Chuquiraga with vitamin C-rich Andean fruits such as camu-camu (Myrciaria dubia) may have empirical pharmacological logic. Pairing with bromelain or other proteolytic enzymes is hypothetically complementary for anti-inflammatory stacks, as enzyme-mediated reduction of pro-inflammatory mediators could amplify the NF-κB suppression attributed to sesquiterpene lactones, though this combination has not been experimentally tested for this genus.

## Frequently Asked Questions

### What is Chuquiraga oppositifolia used for traditionally?

Chuquiraga oppositifolia has been used by indigenous Andean communities in Ecuador at elevations of 3,000–5,000 meters as a medicinal herb, typically prepared as an infusion or decoction of the aerial parts to address inflammatory conditions and support general resilience in high-altitude environments. Specific therapeutic indications in traditional practice have not been formally documented, but broader use of Chuquiraga species in the region aligns with anti-inflammatory and antioxidant applications consistent with the plant's phytochemical profile.

### What are the active compounds in Chuquiraga oppositifolia?

The plant contains sesquiterpene lactones, flavonoids (including quercetin-type compounds measuring approximately 93.37 mg quercetin equivalents/g dry extract in related species), total phenolics (up to 130.13 mg gallic acid equivalents/g dry extract), carotenoids, vitamin C, triterpenes, steroids, and alkaloids, based on analysis of closely related Chuquiraga species. Leaf tissue concentrates higher levels of these bioactives compared to floral tissue, making leaves the preferred fraction in both traditional use and research extracts.

### Are there any clinical trials on Chuquiraga oppositifolia?

No human clinical trials have been published for Chuquiraga oppositifolia or any Chuquiraga species as of the current literature; all available efficacy data come from in vitro cell-free antioxidant assays and rodent inflammation models using related species such as Chuquiraga spinosa and Chuquiraga jussieui. Rodent studies at 250–500 mg/kg showed anti-inflammatory outcomes including paw swelling reductions up to 70.78%, but these preclinical findings have not been translated to human trials.

### Is Chuquiraga oppositifolia safe to consume?

Formal safety data, toxicology studies, and documented adverse event profiles for Chuquiraga oppositifolia do not exist in the published scientific literature, making a definitive safety assessment impossible. Individuals with known Asteraceae (Compositae) family allergies — including allergies to chamomile, feverfew, or arnica — should exercise caution due to potential cross-reactivity with sesquiterpene lactones present in this plant family, and use during pregnancy or lactation is not recommended without medical supervision.

### What is the recommended dose of Chuquiraga oppositifolia?

No standardized human dose has been established for Chuquiraga oppositifolia, as no clinical trials or pharmacokinetic studies have been conducted in humans. Research on closely related species has used crude methanol extracts at 25–100 µg/mL in vitro and 250–500 mg/kg in rodents, while traditional Andean practice suggests daily infusions using approximately 5–10 g of dried plant material per cup of water, though these quantities carry no clinical validation.

### How does Chuquiraga oppositifolia enhance the body's natural antioxidant defenses?

Chuquiraga oppositifolia leaf extracts strengthen your body's endogenous antioxidant enzyme network by elevating reduced glutathione (GSH) levels up to 1.97-fold and boosting catalase activity up to 120.98% above baseline. This upregulation of internal antioxidant systems provides cellular-level protection against oxidative damage without relying solely on exogenous antioxidants. The herb's ability to activate your own defense mechanisms makes it distinct from supplements that simply provide antioxidants directly.

### Which bioactive compounds in Chuquiraga oppositifolia are responsible for its health benefits?

Chuquiraga oppositifolia contains sesquiterpene lactones and polyphenols as its primary bioactive constituents, which work together to inhibit lipid peroxidation and protect cellular membranes from oxidative damage. These compounds are the key drivers of the herb's traditional use and its demonstrated antioxidant and cellular-protective effects in botanical research. The synergistic action of these multiple compound classes contributes to the herb's broader therapeutic profile beyond single-compound supplements.

### What populations may benefit most from Chuquiraga oppositifolia supplementation?

Individuals seeking to enhance cellular antioxidant defenses, particularly those exposed to environmental stressors or oxidative conditions, may benefit from Chuquiraga oppositifolia supplementation. People interested in traditional Andean herbal support and those looking for botanicals that activate endogenous antioxidant pathways rather than relying solely on dietary antioxidants are good candidates for this herb. Those with compromised cellular defense systems due to aging or chronic stress may find particular value in its ability to upregulate glutathione and catalase production.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*